from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3834c/serS

LFCtreatmentdescriptionclass of inhibitor

-0.831

Amikacinug/mL Amikacintranslation

0.255

Cap5-10ug/mL Capreomycintranslation

-0.503

Rox10-50 ug/mL Roxithromycintranslation

-0.325

SM2-5 ug/mL Streptomycintranslation

-0.654

Tet5-10 ug/mL Tetracyclinetranslation

0.426

Rif0.2-5ug/mL Rifampicintranscription

1.257

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.099

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.168

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.095

CPZ10-50 ug/mL Chlorpromazinerespiration

0.083

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.211

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.116

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.842

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.523

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.268

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.775

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.319

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.107

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.211

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.720

KCN5-20 ug/mL Potassium cyaniderespiration

0.046

NaN30.2-2 mM Sodium aziderespiration

0.315

Nigericin50 uM Nigericinrespiration

0.451

TRC10-150 ug/mL Triclosanrespiration

0.662

TRZ10-25 ug/mL Thioridazinerespiration

1.090

Valinomycin0.5-10 uM Valinomycinrespiration

1.130

ZnSO42 mM ZnSO4respiration

-0.475

menadione6-10 ug/mL Menadionerespiration

-0.155

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.120

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.540

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.261

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.855

NRP_1Non-replicating persistence stage 1dosRassociated

0.190

Amp0.2mg/mL AmpicillincellWall

0.067

Cephalexin20-100 ug/mL CephalexincellWall

-0.334

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.636

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.045

EMB10-20 ug/mL EthambutolcellWall

-0.876

Eta12-40 ug/mL EthionamidecellWall

-1.574

INH0.2-0.4 ug/mL IsoniazidcellWall

0.038

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.529

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.528

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.335

BZA0.12 mg/mL BenzamidearomaticAmides

-0.177

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.387

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.051

H2O24 mM hydrogen peroxideDNAdamaging

0.217

Levo10 ug/mL LevofloxacinDNAdamaging

-0.523

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.755

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.365

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.712

UVUV-irradiationDNAdamaging

0.895

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.551

Antimycin12.5-50 ug/mL Antimycin A?

0.119

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.415

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.660

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.173

PA8240.2-2 ug/mL PA-824?

-0.417

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.660

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.235

Verapamil50 uM Verapamil?

1.150

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.264

methoxatin10-20 ug/mL Methoxatin?